Emerald Medical Applications Corp. - Statements of Cash Flows	3 Months Ended
	Mar. 31, 2016 USD ($)	Mar. 31, 2015 USD ($)
Cash flows from operating activities:
Net loss	(1,900,230)	(180,322)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	2,509	399
Amortization of debt discount	1,438	2,071
Change in fair value of derivative	$ 0	$ (367)
Shares issued for services	1,445,653	0
Options issued for services	274,314	0
Increase (decrease) in cash resulting from changes in:
Decrease (increase) in other receivable	$ 25,797	$ (17,333)
(Decrease) increase in accounts payable	17,670	62,828
(Decrease) increase in accrued epenses	(32,394)	0
(Decrease) increase in accrued interest	(7,759)	5,412
Cash flows used by operating activities	(173,002)	(127,312)
Cash flows from investing activities:
Cash paid for fixed assets	0	(6,956)
Net cash provided by investing activities	$ 0	$ (6,956)
Cash flows from financing activities:
Proceeds from issuance of convertible debt	75,000	0
Issuance of non-convertible note	82,250	0
Proceeds from sale of common stock	0	131,798
Cash provided by financing activities	$ 157,250	$ 131,798
Foreign currency adjustments	(4,838)	(9,779)
Net increase (decrease) in cash	$ (20,570)	$ (2,470)
Cash and cash equivalents - beginning of period	115,449	14,411
Cash and cash equivalents - end of period	94,879	2,162
Non-cash transaction:
BCF due to convertible note payable	75,000	0
Cashless conversion of class B warrants	193	0